EP
SCPH

Eversept Partners’s scPharmaceuticals SCPH Stock Holding History

Eversept Partners’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-65,605
Closed -$489K – 69
2020
Q3 		$489K Sell
65,605
-181,814
-73% -$1.42M 0.11% 46
2020
Q2 		$1.82M Buy
247,419
+115,000
+87% +$1.01M 0.3% 51
2020
Q1 		$980K Sell
132,419
-169,217
-56% -$1.23M 0.26% 44
2019
Q4 		$1.71M Buy
301,636
+80,000
+36% +$409K 0.35% 54
2019
Q3 		$1.3M Buy
221,636
+47,339
+27% +$267K 0.41% 40
2019
Q2 		$556K Buy
+174,297
New +$570K 0.16% 57

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return